PULMOPHARMA ApS — Credit Rating and Financial Key Figures

PULMOPHARMA ApS (CVR number: 36428023) is a company from SYDDJURS. The company recorded a gross profit of -20.5 kDKK in 2024. The operating profit was -20.5 kDKK, while net earnings were -20.5 kDKK. The profitability of the company measured by Return on Assets (ROA) was -0.2 %, which can be considered poor and Return on Equity (ROE) was -0.3 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 79.1 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. PULMOPHARMA ApS's liquidity measured by quick ratio was 1.1 which is at a modest level. Thus, the company's liquid assets are in relative balance with its short-term liabilities, indicating a moderate liquidity position. While it's likely to meet its current obligations, financial flexibility may be constrained, and unexpected costs could pose challenges.